Todd Brinton

Todd Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Consulting Associate Professor of Bioengineering at Stanford University. He is an attending general and interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the fellowship director for the Stanford Program in Biodesign since 2005 and also co-directs both the executive education program in innovation management and the Stanford graduate course series in biodesign innovation. Todd Brinton completed his medicine, cardiology, and interventional training at Stanford University. He holds an MD from the Chicago Medical School and a BS in bioengineering from the University of California, San Diego. Along with Shockwave medical, he is co-founder and board director for BioParadox, Inc., another venture-backed medical device company in the cardiovascular space. He was a board director for Infogard laboratories until its acquisition in 2015 (Underwriter’s Laboratories) and was responsible for the early feasibility and clinical development programs for both Kona Medical and Qool Therapeutics. Additonally, he serves on the advisory board of a number of early-stage medical device companies where he focuses on clinical development and strategy. Prior to medical school he was the Clinical Research Director for Pulse Metric, Inc., a medical device start-up company.